What to expect from PEGS Europe 2023: Day 3
Drug Discovery World
NOVEMBER 13, 2023
Laura Mele, PhD, Investigator, GlaxoSmithKline, on: ‘Discovery and characterisation of highly potent Fc-enhanced anti-GPCR mAbs’. They include: Nicolas Poirier, PhD, CSO, OSE Immunotherapeutics, on: ‘Neoepitopes cancer vaccine monotherapy positive efficacy in non-small cell lung cancer with resistance to immunotherapy randomised Phase III’.
57 
Let's personalize your content